Filing Details
- Accession Number:
- 0001140361-23-012810
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-21 16:30:29
- Reporting Period:
- 2023-03-20
- Accepted Time:
- 2023-03-21 16:30:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1484612 | Outset Medical Inc. | OM | Electromedical & Electrotherapeutic Apparatus (3845) | 200514392 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1823381 | L. John Brottem | 3052 Orchard Drive San Jose CA 95134 | General Counsel | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-03-20 | 1,415 | $9.48 | 65,727 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-03-20 | 1,415 | $20.82 | 64,312 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-03-20 | 2,715 | $20.82 | 61,597 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-03-20 | 1,415 | $0.00 | 1,415 | $9.48 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
21,218 | 2030-05-26 | No | 4 | M | Direct |
Footnotes
- Includes 1,422 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2022 to February 28, 2023. This transaction is exempt from Rule 16b-3(c).
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 17, 2023.
- This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.